Stock Events

Stock Events

Stoke Therapeutics (STOK) Q3 2025 Earnings

12AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.53

0.28

1.09

1.9

Details

Expected EPS

-0.512

Actual EPS

-0.4

Surprise EPS

0.11

Surprise Percent

+21.87%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.4 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.